- Home
- FBYD vs OTLK Comparison
FBYD vs OTLK Comparison
Compare FBYD & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBYD
- OTLK
- Stock Information
- Founded
- FBYD 2021
- OTLK 2010
- Country
- FBYD United States
- OTLK United States
- Employees
- FBYD N/A
- OTLK N/A
- Industry
- FBYD
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBYD
- OTLK Health Care
- Exchange
- FBYD Nasdaq
- OTLK Nasdaq
- Market Cap
- FBYD 120.8M
- OTLK 121.8M
- IPO Year
- FBYD N/A
- OTLK 2016
- Fundamental
- Price
- FBYD $9.49
- OTLK $5.41
- Analyst Decision
- FBYD
- OTLK Strong Buy
- Analyst Count
- FBYD 0
- OTLK 7
- Target Price
- FBYD N/A
- OTLK $48.20
- AVG Volume (30 Days)
- FBYD 11.4K
- OTLK 280.9K
- Earning Date
- FBYD 11-14-2024
- OTLK 12-20-2024
- Dividend Yield
- FBYD N/A
- OTLK N/A
- EPS Growth
- FBYD N/A
- OTLK N/A
- EPS
- FBYD N/A
- OTLK N/A
- Revenue
- FBYD $7,042,000.00
- OTLK N/A
- Revenue This Year
- FBYD N/A
- OTLK N/A
- Revenue Next Year
- FBYD N/A
- OTLK N/A
- P/E Ratio
- FBYD N/A
- OTLK N/A
- Revenue Growth
- FBYD N/A
- OTLK N/A
- 52 Week Low
- FBYD $7.02
- OTLK $4.61
- 52 Week High
- FBYD $14.25
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- FBYD 47.87
- OTLK 40.47
- Support Level
- FBYD $9.00
- OTLK $6.17
- Resistance Level
- FBYD $9.79
- OTLK $6.61
- Average True Range (ATR)
- FBYD 0.68
- OTLK 0.36
- MACD
- FBYD 0.02
- OTLK -0.05
- Stochastic Oscillator
- FBYD 41.45
- OTLK 10.80
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.